Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Gavras

Showing results (31-40 of 312) with videos related to

Pageof 32
Sort By:
Recent Progress in Hormone Research|October 14, 1998
Salt in hypertension: physiological and molecular aspectsI Gavras, H Gavras
Journal of Hypertension|May 1, 1991
Cardioprotective potential of angiotensin converting enzyme inhibitorsH Gavras, I Gavras
American Journal of Hypertension|June 20, 2001
Role of alpha2-adrenergic receptors in hypertensionI Gavras, H Gavras
Hospital Practice (Office Ed.)|July 15, 1993
ACE inhibitors: a decade of clinical experienceI Gavras, H Gavras
American Family Physician|April 29, 1998
The calcium channel antagonist controversyI Gavras, H Gavras
Journal of Hypertension|November 1, 1991
Angiotensin converting enzyme inhibitorsH Gavras, I Gavras
Pharmacology|January 1, 1985
Cardiovascular effects of dobutamine and converting enzyme inhibition in rats with diabetic ketoacidosisF Charocopos, H Gavras
Cardiology Clinics|November 1, 1995
Modern approaches to initiating antihypertensive therapyH Gavras, I Gavras
The American Journal of Medicine|October 31, 1986
Clinical utility of angiotensin converting enzyme inhibitors in hypertensionI Gavras, H Gavras
Hypertension (Dallas, Tex. : 1979)|March 1, 1988
Angiotensin converting enzyme inhibitors. Properties and side effectsH Gavras, I Gavras
Pageof 32

Showing results (31-40 of 312) with videos related to

Sort By:
Pageof 32
Recent Progress in Hormone Research|October 14, 1998
Salt in hypertension: physiological and molecular aspectsI Gavras, H Gavras
Journal of Hypertension|May 1, 1991
Cardioprotective potential of angiotensin converting enzyme inhibitorsH Gavras, I Gavras
American Journal of Hypertension|June 20, 2001
Role of alpha2-adrenergic receptors in hypertensionI Gavras, H Gavras
Hospital Practice (Office Ed.)|July 15, 1993
ACE inhibitors: a decade of clinical experienceI Gavras, H Gavras
American Family Physician|April 29, 1998
The calcium channel antagonist controversyI Gavras, H Gavras
Journal of Hypertension|November 1, 1991
Angiotensin converting enzyme inhibitorsH Gavras, I Gavras
Pharmacology|January 1, 1985
Cardiovascular effects of dobutamine and converting enzyme inhibition in rats with diabetic ketoacidosisF Charocopos, H Gavras
Cardiology Clinics|November 1, 1995
Modern approaches to initiating antihypertensive therapyH Gavras, I Gavras
The American Journal of Medicine|October 31, 1986
Clinical utility of angiotensin converting enzyme inhibitors in hypertensionI Gavras, H Gavras
Hypertension (Dallas, Tex. : 1979)|March 1, 1988
Angiotensin converting enzyme inhibitors. Properties and side effectsH Gavras, I Gavras
Pageof 32